Wealthspire Advisors (New York)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.68M | Sell |
|
|||||
|
2025
Q2 | $3.22M | Sell |
|
|||||
|
2025
Q1 | $5.93M | Buy |
|
|||||
|
2024
Q4 | $4M | Sell |
|
|||||
|
2024
Q3 | $8.53M | Buy |
|
|||||
|
2024
Q2 | $493K | Sell |
|
|||||
|
2024
Q1 | $466K | Sell |
|
|||||
|
2023
Q4 | $473K | Buy |
|
|||||
|
2023
Q3 | $377K | Buy |
|
|||||
|
2023
Q2 | $318K | Buy |
|
|||||
|
2023
Q1 | $204K | Sell |
|
|||||
|
2022
Q4 | $207K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $340K | Sell |
|
|||||
|
2020
Q4 | $1.68M | Buy |
|
|||||
|
2020
Q3 | $1.6M | Buy |
|
|||||
|
2020
Q2 | $1.5M | Buy |
|
|||||
|
2020
Q1 | $1.02M | Buy |
|
|||||
|
2019
Q4 | $345K | Sell |
|
|||||
|
2019
Q3 | $262K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $68K | Buy |
|